Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

Health Bulletin 23/August/2022

admin by admin
August 23, 2022
in Pharmaceutical


Here are the top health news for the day:

‘Tomato fever’ misleading colloquial name for hand, foot and mouth disease

Medical professional has informed that Tomato fever is a misleading colloquial name for hand, foot and mouth Disease. Tomato fever (or tomato flu) is a disease that gets its name because of the red and round blisters it causes, which look like tomatoes.

“Tomato fever is a misleading colloquial name for hand, foot and mouth disease. This is a mild viral illness commonly affecting young children typically below age 10. It is usually caused by a Coxsackie virus,” according to Dr Rajeev Jayadevan, co-chairman of IMA’s National task force on COVID-19 reports ANI.

Madras HC upholds Medical Council order barring doctor from practice for two years for issuing fake certificate

Upholding the Tamil Nadu Medical Council (TNMC) order barring a doctor from medical practice for two years, the Division bench of Madras High Court recently slammed the concerned doctor for his involvement in issuing fake medical certificate.

Using the false medical certificate, the property of the deceased patient had been transferred to one of the relative’s name depriving the rights of the daughter of the deceased.

For more details check out the link given below:

Madras HC upholds medical council order barring doctor from practice for two years for issuing fake certificate

NMC releases FAQs based on queries raised by foreign medical graduates from Ukraine, China

Based on queries raised by Foreign Medical Students from Ukraine and China, the National Medical Commission (NMC) has released the Frequently Asked Questions (FAQs) for FMGs.

Medical Dialogues had earlier reported that bringing major relief to foreign medicos hit by the COVID-19 pandemic and Russia-Ukraine war, the National Medical Commission (NMC) decided to frame a scheme and granted relaxation to medical graduates who completed their MBBS course from a foreign medical institute without undergoing physical clinical training.

For more details, check out the link given below:

NMC releases FAQs based on queries raised by foreign medical graduates from Ukraine, China

CDSCO approves AstraZeneca Anticancer drug Trastuzumab Deruxtecan Protocol Amendment

Based on the justification provided by the pharma major AstraZeneca, the Subject Expert Committee(SEC) functional under Central Drug Standard Control Organization(CDSCO) has approved the protocol amendment proposal for anticancer drug Trastuzumab Deruxtecan (T-DXd), which is an antibody used to treat certain types of unresectable or metastatic HER-2 positive breast cancer.

This came after the firm presented justification/rationale vis-a-vis patient safety for the proposed protocol Amendment version 3.0 dated 23-Nov-2021 to the protocol no. D967C00001 before the committee.

For more details, check out the link given below:

CDSCO Approves AstraZeneca Anticancer Drug Trastuzumab Deruxtecan Protocol Amendment



Source link

Tags: AstraZenecabreast cancercancer DrugCDSCOcolloquialfake certificateFMGfoot mouth diseaseForeign Medical StudentsFrequently Asked QuestionsHER-2Madras High CourtMBBSMBBS courseNational Medical CommissionNMCT-DXdTamil Nadu Medical CouncilTomato feverTrastuzumab DeruxtecanTrastuzumab Deruxtecan Protocol Amendment
Previous Post

Topical Gene Therapy Gets Priority Review for Dystrophic Epidermolysis Bullosa

Next Post

The U.S. is at a crossroads for reducing tobacco-related harms

Next Post

The U.S. is at a crossroads for reducing tobacco-related harms

Recommended

CDC Introduces Streamlined Guidelines For Better COVID-19 Protection, Understanding

August 13, 2022

Medical Bulletin 24/December/2022

December 24, 2022

Don't miss it

Pharmaceutical

Strange bedfellows lobby for Medicare obesity-drug coverage

January 26, 2023
Medicines & Healthy Lifestyle

FDA Panel Votes on Rezafungin for Treatment of Candidemia, Invasive Candidiasis

January 26, 2023
Medicines & Healthy Lifestyle

This Cancer Drug Can Increase Longevity, Study Finds

January 26, 2023
News

Something in Breast Milk Helps Protect Babies Against Allergies

January 26, 2023
Pharmaceutical

Merck ends late-stage trial for Keytruda in prostate cancer

January 25, 2023
Medicines & Healthy Lifestyle

Are Seed Oils Behind the Majority of Diseases This Century?

January 25, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.